What are cardiac safety services?

Cardiac safety services are specialized assessments conducted during clinical trials to monitor and evaluate the cardiac health of participants. These services ensure that new drugs or treatments do not pose cardiovascular risks, focusing on measures like ECG monitoring, blood pressure assessments, and thorough QT studies.

How big is the Cardiac Safety Services Market?

The global Cardiac Safety Services Market size was estimated at USD 812.0 Million in 2023 and is expected to reach USD 2,411.6 Million in 2033.

What is the Cardiac Safety Services Market growth?

The global Cardiac Safety Services Market is expected to grow at a compound annual growth rate of 11.5%. From 2024 To 2033

Who are the key companies/players in the Cardiac Safety Services Market?

Some of the key players in the Cardiac Safety Services Markets are Koninklijke Philips N.V., Laboratory Corporation of America Holdings, IQVIA, Ncardia, Certara, SGS SA, Banook, Celerion, Biotrial, NEXEL Co., Ltd, Richmond Pharmacology, PhysioStim, Shanghai Medicilon Inc, Clario

Which regions are leading in the Cardiac Safety Services market?

North America holds a 39% share of the cardiac safety services market in 2023.

What factors are driving the growth of the cardiac safety services market?

The market is driven by the rising prevalence of cardiovascular diseases, increasing clinical trial activities, stringent regulatory requirements, and the growing demand for integrated services that streamline cardiac safety evaluations across trial phases.

What are the emerging trends in the cardiac safety services market?

Emerging trends include the adoption of AI-driven analytics, real-time telemetry monitoring, and the preference for integrated service models that offer comprehensive cardiac safety solutions. Additionally, there is growing interest in expanding services to emerging markets, particularly in the Asia-Pacific region.

Global Cardiac Safety Services Market By Type (Integrated Service, Standalone Service) Service Type (ECG/Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies, Others) By End-User (Pharmaceutical and Biopharmaceutical Companies, Contract Research Organizations, Others) Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033

Published date: Aug 2024
Report ID: 126222
Number of Pages: 285
Format:

- Koninklijke Philips N.V.
- Laboratory Corporation of America Holdings
- IQVIA
- Ncardia
- Certara
- SGS SA
- Banook
- Celerion
- Biotrial
- NEXEL Co., Ltd
- Richmond Pharmacology
- PhysioStim
- Shanghai Medicilon Inc
- Clario
Settings

Related Reports

Our Clients

Inquiry Before Buying

Report ID 126222
Published Date Aug 2024
Rating
- ★★★★★
  
  ★★★★★
- (49)

Buy Now

Trusted by more than 17382 organizations globally

✖

Request a Sample Report

We'll get back to you as quickly as possible

	Single User $6,000 $3,999 USD / per unit save 24%	Multi User $8,000 $5,999 USD / per unit save 28%	Corporate User $10,000 $6,999 USD / per unit save 32%
e-Access
Report Library Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization	No	up to 10 hrs work	up to 30 hrs work
Accessibility	1 User	2-5 User	Unlimited
Analyst Support	up to 20 hrs	up to 40 hrs	up to 50 hrs
Benefit	Up to 20% off on next purchase	Up to 25% off on next purchase	Up to 30% off on next purchase
	Buy Now ($ 3,999)	Buy Now ($ 5,999)	Buy Now ($ 6,999)